Breathe.me

Our goal is to predict and enable preventing the next respiratory attack. Breathe.me developed world's first ultra-low-cost Asthma & COPD monitoring & management solution, using an acoustic sensor and a mobile app for lung function testing. Our technology is patent protected. The sensor is tiny, entirely-mechanical device, that communicates wirelessly with any smartphone. The Acoustic sensor transforms airflow to a varying pitch whistle sound. The sound is recorded by the smartphone and using a proprietary algorithm, the spirometric values (such as peak flow and FEV1) are calculated. The app utilized a disease diary which records measurement results, symptoms, triggers and medication usage.

C-Boot Ltd.

C-Boot develops and manufactures advanced compression products for preventing and treating venous and lymphatic diseases and other conditions that require compression therapy, including DVT prevention. C-Boot offers the first intermittent pneumatic compression (IPC) line of products powered automatically by energy generated from the patient’s body. The company holds proprietary technological knowledge. Patents covering the technological concept and aspects in the field of low pressure compression. The first line of product is already generating revenues through sales to distributors and the company is now focused on expanding its world-wide presence. The manufacturing process is subject to stringent standards of quality assurance. All of C-Boot's products are FDA and CE approved, and the company has been granted the ISO 9001: 2000 and ISO 13485: 2003.

Digma Medical

We are about Restoring Glycemic Control for Type-2 Diabetes & NASH! Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGoneâ„¢ to treat insulin resistance - the underlying mechanism of the disease. The DiaGoneâ„¢ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Controlâ„¢ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGoneâ„¢ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

CEAC Group

tremco rubber & plastic products